Business NewsPR NewsWire • Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses

Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses

Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses

ST. PAUL, Minn., Sept. 30, 2016 /PRNewswire/ -- In the past four years, spending on autoimmune drugs has doubled and utilization has jumped nearly 40 percent in a population of 4.4 million commercially-insured members, according to new research from Prime Therapeutics LLC (Prime), a...

View More : http://www.prnewswire.com/news-releases/prime-therapeutics-finds-autoimmune-specialty-drug-spend-has-doubled-accounts-fo...
Releted News by prnewswire
New York Based Real Estate Firm ABS Management & Development Poised for Aggressive and Visible Growth Becoming a Leading U.S. Based Real Estate Company
Stiff Competition Between Illumina, Thermo Fisher Scientific and Roche in the Next Generation Sequencing Market
Prime Therapeutics Finds Autoimmune Specialty Drug Spend has Doubled, Accounts for 10 Percent of Drug Expenses
Water Treatment Chemicals Market Worth 24.94 Billion USD by 2020
Bulk TV & Internet Makes TBJ List of Best Places to Work